Navigation Links
TGen Drug Development partners with Horizon Discovery for integrated personalized medicine service
Date:4/12/2010

SCOTTSDALE, Ariz., and Cambridge, U.K. April 12, 2010 A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significant advance personalized medicine.

The partnership will create a beginning-to-end solution for pharmaceutical and biotechnology companies to more rationally design and tailor their drugs to specific patient populations based on the unique genetic variations that define a given disease.

TD2 will use Horizon's panel of more than 200 genetically-defined human isogenic cell-lines designed to accurately mirror cancer patient genetics in its comprehensive pre-clinical service as a prelude to performing selected in-house clinical trials. This will provide clients with a fully integrated drug discovery service that will accelerate the isolation and optimization of appropriately targeted therapeutic agents and attain their rapid market approval. And it will save time and money in the development of more effective cancer treatments.

"The future of oncology drug development will require us to predict which patients will respond to what drug," said Dr. Stephen Gately, TD2's President and Chief Scientific Officer, referring to the goal of personalized medicine treating patients with drugs tailor-made for their specific diseases.

"This partnership is the engine that will actually make this work and allow for the design of shorter and less-costly clinical trials that enroll the patients most likely to respond to a given drug," Gately said.

Today's agreement between TD2 and Horizon builds on another agreement announced Feb. 2 between Horizon and TD2's parent organization, the Translational Genomics Research Institute (TGen), to develop new human disease models for TGen's cancer research.

"Working with TD2 will enable us to broaden the impact of our GENESIS and X-MAN technologies in the quest for therapies that target the genetic causes of cancer in e
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Poverty Can Slow Kids Normal Development
2. SCDM to Showcase Professional Development Opportunities at Partnerships Event
3. Urine test for kidney cancer a step closer to development
4. Exposure to 3 classes of common chemicals may affect female development
5. RapidValue Launches iPad Application Development Services for Media & Publishing Firms
6. McMaster researcher leads development of promising drug for inflammation
7. Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases
8. Researchers discover fundamental step in immune-system development
9. EP Global Communications, Inc. Closes First Quarter With Positive Developments
10. Global Development Successes Depend on Access to Water
11. Gene is linked to lung cancer development in never-smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... According to a recent report by iData Research ... the surgical robotics market may find significant ... field dominated by Intuitive. These companies are expected to ... by 2020. , “The MIS robotic device market ... President of iData. “System sales for the da Vinci ...
(Date:11/27/2014)... November 27, 2014 In a ... allot to sleep has lessened, and due to ... the quality of sleep has eroded. According to ... on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This ... index by an incalculable amount, leading not only ...
(Date:11/27/2014)... "As a nurse I see patients every ... incontinence," said an inventor from Whiting, N.J. "I put ... to prevent leakage and keep them dry and comfortable." ... This prevents stains on pants, skirts and bottoms, which ... that the individual has time to get to the ...
(Date:11/27/2014)... babies and young children don,t need medicines if they ... says. Over-the-counter (OTC) cold and cough medicine should ... they could cause serious and potentially deadly side effects, ... colds a year, but children get them more often. ... give them pain relievers, decongestants and other medicines, but ...
(Date:11/27/2014)... In order to enable people to adapt to the ... way to avoid touching a toilet seat and/or lid while ... of the patent-pending Toilet Tamer, a device that enables a ... in a more sanitary manner. It avoids direct contact with ... promotes good hygiene and peace of mind. The portable device ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
... piece of hearty news for cardiac patients who still would ... takes two to tango! And doctors have news that will ... shown that cardiac patients who were assigned waltz classes randomly ... than those cardiac patients assigned to cardiac rehabilitation that chiefly ...
... population based study conducted in Sweden points out that those ... as a result of allergy// to a substance called gluten ... times more prone to developing Type I Diabetes mellitus ... often before the age of twenty. ,Lead author ...
... of Duke University Medical Center, Magnetic Resonance Imaging (MRI) can ... early in patients with the immune system disorder sarcoidosis, who ... ,By using MRI to discover minute areas of heart ... take action to prevent sudden cardiac death, which is a ...
... influential tribal council in the northeastern state of Meghalaya ... rewards for doubling its population to two// million, its ... Council (KHADC), a constitutional body to protect and preserve ... state's Khasi and the Jaintia tribes could become extinct ...
... Researchers from Duke Medical Center have found that pregnant ... death and other medical complications compared to normal// pregnant ... of its kind, was conducted nationwide covering more than ... with systemic lupus should be considered a high-risk population ...
... Talkatora drew thousands of people on Saturday. The three day ... and its// complications. It has been estimated that nearly two ... and therefore a huge attendance was expected on Sunday. ... which in addition to diabetes also focused on various health ...
Cached Medicine News:Health News:From the frying pan into the fire: Celiac disease and diabetes 2Health News:MRI Detects Early Heart Damages In Patients 2Health News:MRI Detects Early Heart Damages In Patients 3Health News:Cash Rewards for Meghalaya Tribes to Encourage Baby Boom 2Health News:Pregnant Women With Lupus Are At Greater Risk 2Health News:Pregnant Women With Lupus Are At Greater Risk 3
(Date:11/26/2014)... PLEASANTON, Calif. , Nov. 26, 2014  Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in two upcoming investor conferences. On ... 26 th Annual Piper Jaffray Healthcare Conference.  ... will provide an update on the company beginning at ...
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
(Date:11/26/2014)... VIEJO, Calif. , Nov. 26, 2014 /PRNewswire/ ... announced that the U.S. Food and Drug Administration ... its New Drug Application (NDA) for AVP-825. AVP-825 ... low-dose sumatriptan powder delivered intranasally utilizing a novel ... the Complete Response letter, and consistent with the ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
... Federal, state and local dignitaries ushered in a ... with the dedication of a laboratory complex designed to ... The complex, housing 78 labs and other facilities, ... combining scientists from different fields and allowing them to ...
... Md., Oct 21, 2011 /PRNewswire-iReach/ -- ... accreditation for their Maryland Campus from the Accrediting Bureau ... meeting. ABHES is recognized by the United ... postsecondary institutions in the United States offering predominantly allied ...
Cached Medicine Technology:MUSC Dedicates New Bioengineering and Drug Discovery Hubs 2Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... easy on delicate urethral tissues. ... hydrophilic coating provide nearly friction-free ... It's easy to maintain sterility. ... with its own sterile water, ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products: